Asset Details
Do you wish to reserve the book?
Cardiovascular Imaging Databases: Building Machine Learning Algorithms for Regenerative Medicine
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Cardiovascular Imaging Databases: Building Machine Learning Algorithms for Regenerative Medicine
Do you wish to request the book?
Cardiovascular Imaging Databases: Building Machine Learning Algorithms for Regenerative Medicine
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
Cardiovascular Imaging Databases: Building Machine Learning Algorithms for Regenerative Medicine
2022
Overview
Purpose of Review
Myocardial regeneration is a promising alternative to heart transplantation, but the ideal stem cell type remains unknown due to conflicting results in clinical trials. Trial discrepancies may be addressed by standardizing cell handling protocols, broadening clinical endpoints, and selecting patients likely to benefit from cell therapy. Machine learning can potentially assist with these tasks.
Recent Findings
We introduce machine learning and review literature with the most efficacious results translatable to regenerative cardiology, such as in quality control systems during cell culturing, automated segmentation, and myocardial tissue characterization. Investigators are then cautioned on potential pitfalls and offered solutions to minimize model biasing.
Summary
Standardizing imaging with automated segmentation can improve the quantification of left ventricular endpoints. Additionally, myocardial textural analysis has significant potential to uncover hidden biomarkers, which may address the need for novel clinical endpoints. Lastly, phenogrouping through radiomics signatures can assist in appropriating patients likely to respond to stem cell therapy.
Publisher
Springer International Publishing,Springer Nature B.V
